N/A
Completed N=441
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
Stage 0 Skin Melanoma · Stage I Skin Melanoma · Stage IA Skin Melanoma · Stage IB Skin Melanoma
Source: ClinicalTrials.gov NCT03028948 ↗
Enrolled (actual)
441
Serious AEs
—
Results posted
Feb 2023
Primary outcomePrimary: Sun Protection Behavior Index — 3.54; 3.37 scores on a scale
Summary
This clinical trial studies how well an interactive tailored website works in promoting sun protection and skin self-check behaviors in patients with stage 0-III melanoma. An internet-based program may help individuals to perform skin self-checks and engage in sun protection behaviors.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Sun Protection Behavior Index |
3.65; 3.52 | — |
| PRIMARY Number of Participants That Performed a Thorough Skin Self-examination (SSE) in the Past 2 Months |
59; 16; 139; 199 | — |
| SECONDARY Performance of Thorough Skin-self-examination (SSE) in the Past 4 Months |
54; 24; 132; 182; 3; 1 | — |
| SECONDARY Performance of Thorough Skin-self-examination (SSE) in the Past 6 Months |
54; 26; 121; 169; 5; 7 | — |
| SECONDARY Number of SSEs Performed |
— | — |
| SECONDARY Number of Body Areas Examined |
— | — |
| SECONDARY Use of Tools to Facilitate SSE |
— | — |
| SECONDARY Frequency of Engaging in Each Individual Sun Protection Behavior From the Sun Protection Behavior Index |
— | — |
| SECONDARY Number of Sunburns |
— | — |
| SECONDARY Wearing Long Pants |
— | — |
| SECONDARY Wearing Sunglasses |
— | — |
| SECONDARY Sunbathing |
— | — |
| SECONDARY Sun Protection Behavior Index |
3.65; 3.52 | — |
Eligibility Criteria
Inclusion Criteria
- Phase I: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma
- Phase I: From 3-36 months post-surgical treatment
- Phase I: Access to the internet
- Phase I: Able to speak and read English
- Phase I: Able to provide informed consent
- Phase II: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma
- Phase II: From 3-24 months post-surgical treatment
- Phase II: Not adherent to thorough SSE (i.e., did not check every area of the body at least once during the past 2 months)
- Phase II: Not adherent to sun protection recommendations (i.e., mean score < 4 [which corresponds to "often"] on a 5-point scale [from 1 = "never" to 5 = "always"] that assesses the frequency of engaging in four sun protection behaviors)
- Phase II: Access to a computer connected to the internet
- Phase II: Able to speak and read English
- Phase II: Able to provide informed consent
Data sourced from ClinicalTrials.gov (NCT03028948). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.